ENZO热销产品—— Angiotensin II ELISA kit
血管紧张素是来源于血管紧张素原的小肽。几种已知的血管紧张素是调节血压的既定内分泌效应物，但它们也已知在一些器官和组织（旁分泌）和细胞水平（自分泌/内分泌）具有其他局部功能。血管紧张素I(DRVYIHPFHL)没有已知的效应器功能，但它是血管紧张素II(DRVYIHPF)的直接前体。血管紧张素II与AT1受体结合，促进血管收缩、钠潴留、醛固酮的释放、氩加压素的释放、细胞增生、炎症、纤维化、焦虑和心脏肥大。血管紧张素A(ARVYIHPF)，和血管紧张素III(RVYIHPF)，也与AT1受体结合。血管紧张素(1-7)(DRVYIHP)结合不同的受体，称为MAS-1，具有相反的作用（血管扩张、利尿、抗扩散、NO释放、PGE释放和细胞凋亡）。血管紧张素IV(VYIHPF)与另一个称为AT4(IRAP)的受体结合，促进血流增加、血管生成和利尿，它也与记忆的形成和阿尔茨海默病的发病机制有关。肽LVV-hemorphin-7（LVVYPWTQRF）不是血管紧张素，但也能与AT4受体结合。还有其他已经确定的血管紧张素肽，包括Ang(1-9)(DRVYIHPFH)、Ang(1-12)(DRVYIHPFHLVI)、Ang V(3-7)(VYIHP)，以及其他几种功能未定的短肽。
ENZO Angiotensin II ELISA kit是一种比色竞争法免疫检测试剂盒，3.5小时内即可得到结果。
● 高度特异性，与类似肽交叉反应性低
● 超越半定量Western blot分析的全定量检测
● 易于使用的液体颜色编码试剂，最大限度地减少错误
● 即用型试剂和预包被板可减少错误并节省您的时间
产品信息
|
产品货号
|
ADI-900-204
|
|
产品名称
|
Angiotensin II ELISA kit（血管紧张素ⅡELISA试剂盒）
|
|
规格
|
96 wells
|
|
灵敏度
|
4.6 pg/ml
|
|
检测范围
|
3.9-10,000 pg/ml
|
|
检测时间
|
3.5 hours
|
|
样本种属
|
Species independent
|
|
样本类型
|
plasma and serum
|
|
保存温度
|
Store all components at +4ºC, except Standard at -20ºC.
|
|
试剂盒组分
|
Microtiter Plate, Conjugate, Antibody, Assay Buffer 16, Wash Buffer Concentrate, Standard, TMB Substrate, Stop Solution 2, Streptavidin-HRP
|
部分产品引用文献
1. ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury: T. Minato, et al.; PLoS One 17, e0270920 (2022)
2. Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19: L. Kundra, et al.; J. Allergy Clin. Immunol. 150, 594 (2022)
3. Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries: S.V. Dangudubiyyam, et al.; Biol. Reprod. 107, 1072 (2022)
4. Rapeseed (canola) oil aggravates metabolic syndrome-like conditions in male but not in female stroke-prone spontaneously hypertensive rats (SHRSP): M. Nishikawa, et al.; Toxicol. Rep. 9, 256 (2022)
5. Vasorin plays a critical role in vascular smooth muscle cells and arterial function: L. Louvet, et al.; J. Cell. Physiol. 237, 3845 (2022)
6. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury: T. Yamaguchi, et al.; Nat. Commun. 12, 6791 (2021)
7. Advanced Oxidation Protein Product Promotes Oxidative Accentuation in Renal Epithelial Cells via the Soluble (Pro)renin Receptor-Mediated Intrarenal Renin-Angiotensin System and Nox4-H2O2 Signaling: K. Xue, et al.; Oxid. Med. Cell. Longev. 2021, 5710440 (2021)
8. Letter to the Editor – Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report: B.M. Henry, et al.; Prog. Cardiovasc. Dis. 63, 702 (2021), Application(s): Human plasma
9. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19: S. Espino-Y-Sosa, et al.; Viruses 13, 1906 (2021)
10. The Expression of RAAS Key Receptors, Agtr2 and Bdkrb1, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome: M. Punapart, et al.; Genes (Basel) 12, 1717 (2021)
11. B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction: T. Minato, et al.; Nat. Commun. 11, 1058 (2020)
12. Diabetes-induced Upregulation of Kallistatin Levels Exacerbates Diabetic Nephropathy via RAS Activation: Y. Yang, et al.; FASEB J. 34, 8428 (2020)
13. Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19: M. Reider, et al.; Am. J. Hypertens. 2020, hpaa169 (2020)
更多详情请咨询Enzo Life Sciences全国代理商-上海金畔生物
